CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Understanding How New Data Integrity Regulations Apply to Your GDP Temperature-controlled Pharmaceuticals

The 2015 UK Data Integrity Guidance states raw data must be
“legible and accessible, retained in the format in which it was
originally generated, throughout the data lifecycle”. From a business
perspective, we know that raw data generated in the supply chain
is valuable to understanding its performance – if handled correctly.
But how? It’s more efficient to ensure raw data is connected to
the original data record, which can be done using a relational
database. If you’re manually processing flat files, it can be resourceintensive
to review numerous spreadsheets, for example, and more
subject to error when archiving and storing paper records or flat
files. Courtney Becker-James, Strategic Marketing Director at
Elpro, helps to understand how new data integrity regulations apply
to your GDP temperature-controlled pharmaceuticals.
https://international-pharma.com/wp-content/uploads/2016/07/L-L-2-Understanding-How.pdf

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026